Men Who Have Sex with Men

The brief provides an update of the local mpox situation and vaccinations as of November 2024.

The infographic shows the results of a survey given to people, attending Pride and other community events, who have been vaccinated against mpox.

Kelly et al., 2024, led by Dr. Nicole Kelly from UC San Diego with co-authors at the University of North Carolina, examines the profound impact of state and local LGBTQ+ policies on HIV prevention among young SGM people, especially Black youth. The study highlights that PrEP (pre-exposure prophylaxis) use among young people significantly increases in regions with protective LGBTQ+ legislation, while discriminatory policies hinder access to life-saving prevention tools

For 340B-covered entities, core to the challenge of navigating a changing and uncertain policy landscape is the complexity of how multiple variables interact differently with each covered health care entity based on its unique makeup of services, funding, patient population, and payer mix. This toolkit aims to assist 340B covered entities in understanding their current areas of funding stability and where they are vulnerable, and to plan for the future.

In light of proposed and actual changes in Federal and State policy that have the potential to affect the 340B program, we conducted a rapid response study, exploring the impact to facilities that serve people living with or at risk for HIV. As a companion to the Navigating 340B Toolkit, this Explainer takes a closer look at the answers to these three questions: 1. How does 340B work? 2. What is the relationship between 340B and HIV services? 3. What are the current factors impacting 340B revenue for HIV clinical and service organizations?

Policy brief based on a study of seven California emergency departments (ED) implementing HIV Prevention Services (HPS) linkage programs. Three models for integrating HPS into the ED were identified and may serve as a guide for future protocol development.

Paper A Systematic Review of HIV Pre-exposure Prophylaxis (PrEP) Implementation in U.S. Emergency Departments: Patient Screening, Prescribing, and Linkage to Care January 18, 2024 Systematic Review of peer-reviewed quantitative studies and conference abstracts addressing PrEP screening, prescribing, and/or linkage to PrEP care in US Emergency Departments. Further research into the best practices for integrating ED […]

Infographic Zero-Cost Preventative Care for Californians & Extended Coverage for STI Screenings September 10, 2023 Employer coverage for PrEP is at risk—proposed legislation in California seeks to preserve and extend coverage for PrEP and other preventative care. Learn more about the Texas case Braidwood Management v. Becerra and what California Assembly Bill 1645 will do to address […]

Policy Brief Are California pharmacists ready to provide long-acting injectable pre- exposure prophylaxis (PrEP) for HIV prevention? July 31, 2023 A new CHPRC analysis finds strong potential to increase access to long-acting injectable forms of HIV prevention in California pharmacies. Pharmacists surveyed were highly supportive of pharmacy-based PrEP provision under Senate Bill 159, and more […]

Policy Brief People Living With HIV who Smoke Face Barriers to Accessing Smoking Cessation Services in Southern California HIV Safety Nets May 15, 2023 A new study from the California HIV/AIDS Policy Research Centers finds that less than 30% of safety net providers in the Ryan White HIV/AIDS Program in Southern California offered smoking cessation […]